EdaƱo, Eufemia P.
HRN: 22-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2023
06/06/2023
IV
1.5gram
Q8hrs
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes